Market Overview

"People with diabetes require at least 2-3 times the health care resources compared to people who do not have diabetes, and diabetes care may account for up to 15 % of national healthcare budgets". Read more about the risk categories for future development of diabetes and cardiovascular disease under WHO (World Health Organization): "Raised fasting blood glucose".)"

Our easy to use lateral flow test can be used for all individuals at a high risk (e.g. obesity, family history of diabetes etc.). It is simple, easy to perform, and can be used everywhere by patients, bought from a drugstore, or from health care providers.

Early detection of diabetes type 2 will save you money. In parallel countrywide communities, health insurance companies and dominant employers may save Billions of USD every year starting with an early treatment against the disease. Continuously, the estimated diabetes costs in the US for direct medical costs are $176 billion and the indirect costs are $ 69 billion for disability, work loss, premature death (Source Centers for Disease Control (CDC): National Diabetes Statistics Report, 2014, US.

Based on numbers from the IDF Diabetesatlas 2015 one in eleven adults have diabetes (415 million) and 46.5% of adults with diabetes are undiagnosed. 12% of global health expenditure is spent on diabetes care ($673 billion). Every six seconds a person dies from diabetes.

Again: Our lateral flow test should be accessible to all individuals. The test is a big value for different special groups of clients, clients who have the duty to do annual health checks. For example, employees in the airline industry, in all parts of public transportation and in the military forces - annually.

Health insurance companies in the US should be very interested in the proinsulin POCT. The insured individual is protecting themselves against the development of type 2 diabetes and does not need the financial support of insurance for diabetes. A real benefit for both sides: the insured individual and the insurance company.